Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from InfuSystem Holdings ( (INFU) ).
InfuSystem Holdings, Inc., a national health care service provider focused on outpatient clinic-to-home care for complex durable medical equipment, operates across Patient Services and Device Solutions platforms serving oncology, pain management and wound therapy markets. Based in Rochester Hills, Mich., the company supports providers and payers with equipment rentals, pump and consumable sales, and biomedical services through field teams and Centers of Excellence in the U.S. and Canada.
On May 18, 2026, InfuSystem announced that its board approved a new stock repurchase program authorizing up to $20 million of common stock repurchases between July 1, 2026 and June 30, 2028, replacing an existing authorization expiring June 30, 2026. The company had already repurchased about 1.6 million shares for approximately $11.9 million through March 31, 2026, and management framed the renewed buyback as a reflection of balance-sheet strength, ongoing profitable growth and a capital allocation strategy that prioritizes strategic investments while allowing opportunistic share repurchases to enhance shareholder value.
The most recent analyst rating on (INFU) stock is a Buy with a $17.50 price target. To see the full list of analyst forecasts on InfuSystem Holdings stock, see the INFU Stock Forecast page.
Spark’s Take on INFU Stock
According to Spark, TipRanks’ AI Analyst, INFU is a Neutral.
The score is driven primarily by improved margins and cash generation but is held back by the sharp TTM revenue contraction. Weak technicals (price below key moving averages with negative MACD) and a high P/E with no dividend support further weigh on the rating, while earnings-call guidance and liquidity provide some offset.
To see Spark’s full report on INFU stock, click here.
More about InfuSystem Holdings
InfuSystem Holdings, Inc. is a leading U.S. health care service provider that facilitates outpatient care for durable medical equipment manufacturers and health care providers through a two-platform model. Its Patient Services segment focuses on clinic-to-home treatments in oncology, pain management and wound therapy, while its Device Solutions segment provides direct payer rentals, pump and consumable sales, and biomedical services and repairs, supported by field-based teams and Centers of Excellence across North America.
Headquartered in Rochester Hills, Mich., the company’s integrated platforms position it as a key last-mile provider for complex home-based therapies, leveraging local support and a strong service orientation to win incremental business from payers and providers. This structure enables InfuSystem to align device supply, maintenance and patient-facing services in a way that supports sustainable growth in outpatient and home-care markets.
Average Trading Volume: 144,401
Technical Sentiment Signal: Hold
Current Market Cap: $177M
See more insights into INFU stock on TipRanks’ Stock Analysis page.